Submitted by Anonymous (not verified) on 11 October 2024 - 12:00
Human medicines European public assessment report (EPAR): Abevmy, bevacizumab, Date of authorisation: 21/04/2021, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Abevmy, bevacizumab, Date of authorisation: 21/04/2021, Revision: 9, Status: Authorised